We are live on ! Find out more
VAR

Varian Medical Systems, Inc.
VAR

Delisted

VAR was delisted on the 14th of April, 2021.

550 hedge funds and large institutions have $9.49B invested in Varian Medical Systems, Inc. in 2017 Q2 according to their latest regulatory filings, with 73 funds opening new positions, 166 increasing their positions, 213 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 73 | Existing positions closed: 41

77% more call options, than puts

Call options by funds: $25.4M | Put options by funds: $14.3M

13% more capital invested

Capital invested by funds: $8.4B → $9.49B (+$1.09B)

5% more funds holding

Funds holding: 522550 (+28)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

22% less repeat investments, than reductions

Existing positions increased: 166 | Existing positions reduced: 213

Holders
550
Holders Change
+28
Holders Change %
+5.36%
% of All Funds
13.71%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.15%
New
73
Increased
166
Reduced
213
Closed
41
Calls
$25.4M
Puts
$14.3M
Net Calls
+$11.1M
Net Calls Change
+$27.7M
Name Holding Trade Value Shares
Change
Change in
Stake
WAM
301
World Asset Management
Michigan
$954K -$130K -1,351 -13%
SAM
302
Securian Asset Management
Minnesota
$940K -$28.9K -300 -3%
BWM
303
BerganKDV Wealth Management
Minnesota
$935K -$45.5K -472 -5%
Nomura Holdings
304
Nomura Holdings
Japan
$931K +$869K +9,019 New
EHC
305
Everett Harris & Co
California
$929K -$8.19K -85 -0.9%
JIM
306
Jensen Investment Management
Oregon
$926K +$341K +3,540 +65%
ProShare Advisors
307
ProShare Advisors
Maryland
$924K -$42.9K -445 -5%
CG
308
Caprock Group
Idaho
$918K +$867 +9 +0.1%
CAM
309
Cypress Asset Management
Texas
$903K -$14.4K -150 -2%
MIS
310
Morningstar Investment Services
Illinois
$893K -$281K -2,920 -25%
MAM
311
Meeder Asset Management
Ohio
$885K +$4.72K +49 +0.6%
TA
312
Tiedemann Advisors
New York
$876K +$577K +5,993 +240%
LPL Financial
313
LPL Financial
California
$870K +$821K +8,520 New
GT
314
Glenview Trust
Kentucky
$858K
M&T Bank
315
M&T Bank
New York
$846K -$863K -8,965 -52%
SEC
316
Seven Eight Capital
New York
$846K +$790K +8,200 New
First Trust Advisors
317
First Trust Advisors
Illinois
$844K -$14M -145,603 -95%
SRC
318
Stone Run Capital
New York
$840K
LIA
319
LS Investment Advisors
Michigan
$832K +$5.78K +60 +0.7%
SNT
320
Security National Trust
West Virginia
$826K
NMERB
321
New Mexico Educational Retirement Board
New Mexico
$825K -$96.3K -1,000 -11%
GXMC
322
Global X Management Company
New York
$824K -$31.2K -324 -4%
ACP
323
Ashfield Capital Partners
California
$815K +$530K +5,507 +231%
DIA
324
Dean Investment Associates
Ohio
$813K -$44.6K -463 -6%
TFA
325
Transamerica Financial Advisors
Florida
$810K -$6.55K -68 -0.9%

VAR Hedge Fund Activity: Q2 2017 in Review

550 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Varian Medical Systems, Inc. (VAR) for Q2 2017, worth a combined $9.49B — up 13% from $8.4B a quarter earlier.

Buyers outnumbered sellers: 73 funds opened new VAR positions and 41 closed out — a net gain of 32 holders — while 166 added to existing stakes and 213 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $340M. The largest seller was Generation Investment Management, exiting entirely with an estimated $227M sold.

  • 550 institutional investors held Varian Medical Systems, Inc. (VAR) as of Q2 2017, up from 522 in Q1 2017.
  • Funds reported $9.49B of Varian Medical Systems, Inc. stock for Q2 2017, up 13% quarter-over-quarter.
  • 73 funds opened new Varian Medical Systems, Inc. positions in Q2 2017 and 41 closed out, a net change of +32 holders.
  • The largest Varian Medical Systems, Inc. buyer in Q2 2017 was Janus Henderson Group, an estimated $340M added.
  • The largest Varian Medical Systems, Inc. seller in Q2 2017 was Generation Investment Management, an estimated $227M sold.

Based on aggregated 13F filings for Q2 2017.